Linezolid for Syphilis Pilot Study (NCT05548426)

🧪 Interventions in This Study

• Group B, Linezolid 10d (DRUG)
• Group A, Penicillin (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (5 Sites)

• Howard Brown Health — Chicago, Illinois
• Open Arms HealthCare Center — Jackson, Mississippi
• University of Mississippi Medical Center — Jackson, Mississippi
• Wake Forest Baptist Health — Greensboro, North Carolina
• Open Door Health — Providence, Rhode Island

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Syphilis

• Investigational Study to Evaluate the DPP® Syphilis Screen & Confirm Antibody Point-of-care Test (POCT) to Diagnose Infectious Syphilis — Winnipeg, Manitoba
• Offering Routine and Rapid Point of Care (POC) Syphilis Testing in Pregnant Patients Presenting to the Emergency Department — Houston, Texas
• Daily Doxycycline for Early Syphillis — Seattle, Washington
• Cefixime Clinical Trial — Los Angeles, California
• A Cross-sectional Investigational Study to Evaluate the Sensitivity, Specificity, and Utility of the MedMira Inc. Multiplo® Complete Syphilis (TP/nTP) Antibody Test (POCT) to Diagnose Infectious Syphilis in Participants Attending the Sexual Health Clinic in Ottawa, Ontario. — Ottawa, Ontario

Explore by condition: All Syphilis clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.